Disease Areas and Therapies

Single Cell Analysis in Next-Generation Sequencing Markets (NGS): Market Size and Forecast, Segment Breakouts, Secondary Research, 2022-2027 delves into the rapidly growing market for single cell genomics products, including hardware, software, consumables, and services associated with sequencing and downstream analysis.

 

Report Highlights:

• Market Overview:
  • Detailed analysis of the single cell genomics market,…

Gain valuable insights into the evolving COVID-19 testing market with Kalorama Information’s comprehensive report, COVID-19 Testing Market Update, 2022. This report offers detailed market sizing and estimates for various COVID-19 tests and explores the market impacts of the ongoing pandemic. Throughout 2021 and into 2022, the relentless presence of COVID-19 has significantly influenced laboratories and…

As one of the largest and fastest-growing segments in the in vitro diagnostics (IVD) industry, infectious disease testing is crucial for detecting and identifying pathogens, pinpointing their origins, and determining appropriate antimicrobial therapies.

Kalorama Information’s Infectious Disease Diagnostic Testing: World Market Analysis, 2022 examines market drivers, including external influences that promote the development and use…

Cardiovascular diseases, including those affecting the heart and brain’s blood vessels, are the leading cause of death globally. With the incidence of cardiovascular disease rising sharply, the demand for cardiac markers is increasing, driving constant research and development for improved diagnostics.

Kalorama Information’s World Market for Cardiac Markers (POC and Lab-Based), 2021-2026 provides crucial insights…

Stay informed with the latest trends and developments in the IVD market with IVD Trends and Market Update, March 2022 from Kalorama Information. The report reflects the latest industry insights as of Q1 2022. This comprehensive report examines the critical factors driving growth, major trends, and the ongoing impact of COVID-19 on the IVD industry.

…

There were over 100 billion IVD procedures in 2021.  These represent sources of revenue for IVD companies and laboratories, but they also represent gateway activities to a broad range of healthcare events including surgeries, pharmaceutical prescriptions imaging procedures and physician office visits. Finding information for procedure volumes can be difficult as companies do not publish…

The cell and gene therapy (CGT) sector has experienced remarkable growth, with funding reaching $70 billion in 2021. As barriers to entry lower and the number of approved therapies with proven track records increases, over a thousand companies have entered or expanded within this dynamic field. Keeping up with this rapidly evolving industry is essential,…

Stay ahead in the rapidly evolving cell and gene therapy (CGT) industry with our comprehensive market analysis from Kalorama Information. Cell Therapy and Gene Therapy Markets, 2021-2031 covers market segments, disease epidemiology, and competitive landscapes, providing valuable insights for stakeholders.

Market Segmentation and Analysis:

• Product Segments: Detailed market estimates and forecasts for dermatological, cardiovascular-blood,…

Kalorama Information presents a comprehensive analysis of the evolving global blood screening market in its latest report, World Market for Blood Screening, 2022. This multibillion-dollar market is crucial for ensuring the safety of the blood supply by detecting infectious diseases and conditions. The report provides insights into market dynamics, technological advancements, and regional developments, making…

Unlock valuable insights and data points for strategic business planning with Kalorama Information’s comprehensive report, The World Liquid Biopsy Market, 2021. This report delves into various facets of the liquid biopsy market, providing a detailed analysis that is crucial for stakeholders in the healthcare and diagnostics industry.

 

Market Highlights:

• Research vs. Clinical Liquid…

The viral vectors market is evolving with advancements in gene therapy and vaccine technologies. New developments are enabling viral vectors to produce stable, non-toxic, and safe therapeutic outcomes. As the industry moves towards standardized and automated manufacturing processes, the potential for viral vectors in treating cancers, genetic diseases, and other conditions continues to grow. Kalorama…

Kalorama Information’s The World Market for Cancer Diagnostics, 2021 offers an in-depth and authoritative analysis of the rapidly evolving cancer testing industry. This comprehensive report provides market sizing, opportunity assessments, and insights into industry mergers and trends, essential for stakeholders and decision-makers in the healthcare sector.

 

Market Segments:

Explore detailed market data across key…